A bright, motivating hemp gummy designed to help you feel more you — whether you’re chasing a workout high, powering through a creative project, or simply embracing a more energized day.
If you’ve ever wished hemp gummies could give you a little more get up and go instead of sink into the couch, we made this for you. The New Workout Plan is a unique blend of cannabinoids—THCV, CBG, and CBC—that’s crafted to support motivation, focus, and clarity without heavy sedation.
Why THCV, CBG, and CBC?
Most hemp edibles lean toward relaxation and sedation, thanks to high levels of THC and CBD. That’s great for winding down—but what about when you want to turn things on?
Here’s what makes our cannabinoid blend special:
- THCV – Known as the “sports car” of cannabinoids, THCV is being studied for its potential to boost energy, support mental clarity, and even help regulate appetite.
- CBG – The “mother cannabinoid” offers a gentle, clear-headed lift and may enhance focus and mood.
- CBC – Less famous but equally fascinating, CBC has been linked to supporting mood balance and brain health.
Together, these three cannabinoids create a uniquely uplifting hemp gummy experience that helps you lean into life with intention.
A Gummy That Moves With You
Whether you’re:
- Heading to the gym for a morning lift
- Stepping into a brainstorming session
- Tackling your to-do list with fresh focus
- Or dancing in your living room to your “Power Hour” playlist
The New Workout Plan helps keep your mind engaged and your energy high—without the drowsy after-effect.
Use It Intentionally
Like all Heylo products, these gummies are designed for intentional cannabis use. Think about when and why you’re taking them—your morning workout, a creative sprint, or that mid-afternoon slump—and let the cannabinoids enhance the moment.
Get More Out of Life by making your cannabis experience fit your goals—not the other way around. Try The New Workout Plan and see how uplifting hemp can be.
References:
- Wargent, E.T., & Tschöp, M.H. (2021). Cannabinoids and metabolic regulation. Pharmacology & Therapeutics, 219, 107702.
- Brierley, D.I., & Davidson, C. (2012). Developments in cannabinoids as anti-obesity drugs. Expert Opinion on Investigational Drugs, 21(6), 913–925.
- Cascio, M.G., et al. (2010). Evidence that the plant cannabinoid cannabichromene is a selective CB2 receptor agonist. British Journal of Pharmacology, 160(3), 585–596.
- Borrelli, F., et al. (2013). Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats. Psychopharmacology, 230(4), 681–691.
